?url_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.aulast=Yates&rft.aufirst=Tom+A&rft.au=Yates%2C+Tom+A&rft.date=15+March+2025&rft.atitle=Primary+efficacy+endpoints+in+phase+3+non-inferiority+trials+to+establish+new+tuberculosis+treatment+regimens+should+only+include+microbiological+outcomes&rft.issn=2666-5247&rft.title=The+Lancet+Microbe&rft.genre=article